- $34.79m
- $16.73m
- $27.24m
- 92
- 55
- 75
- 87
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8.82 | 9.47 | 19.6 | 26.5 | 27.2 |
Cost of Revenue | |||||
Gross Profit | 7.44 | 8.28 | 18.4 | 24.9 | 25 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11.7 | 9.87 | 11.5 | 14.7 | 34.2 |
Operating Profit | -2.89 | -0.403 | 8.02 | 11.8 | -6.91 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.33 | -0.544 | 8.05 | 11.6 | -6.56 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.34 | -0.559 | 8.25 | 9.71 | -6.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -3.34 | -0.559 | 8.25 | 9.71 | -6.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.34 | -0.559 | 8.25 | 9.71 | -6.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.332 | -0.05 | 0.577 | 0.654 | -0.03 |